IPM clocks Rs 10,278 cr in Sept 2016
Domestic companies continued to dominate the market with a 79 per cent share
Author
EMA accepts for review Mylan and Biocon’s Regulatory Submission for Insulin Glargine
It includes analytical, functional and pre-clinical data, as well as results from PK and confirmatory efficacy/safety global…
Vyome Biosciences administers first in-human dose of VB 1953 in US
The Phase 1 clinical study was conducted in patients with facial acne
Ajanta Pharma launches BP lowering tablets in US
The company’s product is a generic version of Daiichi Sankyo's Azor tablets
Strides Shasun receives US FDA approval for Abacavir Tablets
Abacavir Tablets is indicated for the treatment of HIV-1 infection
Novartis wins two Prix Galien Foundation Awards
Gleevec recognised as 'Discovery of the Decade' for Best Pharmaceutical Product, Cosentyx as Best Biotechnology Product
Advanced Enzyme Technologies in agreement with JC Biotech
To acquire a 70 per cent stake for a consideration of Rs 50 crores
Strides Shasun announces Q2 FY17 results
Revenues has been posted at Rs 9,461 million, showing a growth of 33 per cent Y-o-Y